The FDA decision was based on results from three late-stage clinical studies, including two Phase 3 trials conducted in ...

Vanda Pharmaceuticals said on Tuesday its drug for the prevention of motion-induced vomiting was approved by the U.S. health ...

The U.S. FDA has approved its first pharma treatment in more than 40 years for motion sickness. The green light for Nereus (tradipitant), from Vanda Pharmaceuticals Inc., was based on three clinical ...

Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) shares are trading higher Wednesday after the company announced it received FDA ...

Vanda Pharmaceuticals has received approval from the U.S. Food and Drug Administration (FDA) for its drug tradipitant, ...

Vanda Pharmaceuticals, Inc. VNDA announced that the FDA has approved its candidate tradipitant for the prevention of vomiting ...

Don’t tell Neil Armstrong, but giant leaps for mankind may leave astronauts feeling a little queasy. In a new experiment, aerospace engineers at the University of Colorado Boulder will work with ...

The FDA's usual end-of-year flurry of regulatory approvals is a little lighter than usual, but the agency has delivered some ...

Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has ...

Motion sickness sufferers will know all too well how feelings of nausea can linger even after movement has stopped. But researchers in China may have found a way to speed up recovery — listen to happy ...

A new study explored why the severity of motion sickness varies from person to person by investigating sources of cybersickness during VR use. A new study led by Head of the Rokers Vision Laboratory ...